Advanced search
Publication Cover
Expert Review of Hematology Volume 7, 2014 - Issue 6
Submit an article Journal homepage
429
Views
13
CrossRef citations to date
0
Altmetric
Drug Profiles

Pomalidomide for multiple myeloma

Guillemette FouquetService des maladies du sang, hôpital Huriez, CHRU de Lille, rue M. Polonovski, 59037 Lille, France
,
Claire BoriesService des maladies du sang, hôpital Huriez, CHRU de Lille, rue M. Polonovski, 59037 Lille, France
,
Stéphanie GuidezService des maladies du sang, hôpital Huriez, CHRU de Lille, rue M. Polonovski, 59037 Lille, France
,
Loïc RenaudService des maladies du sang, hôpital Huriez, CHRU de Lille, rue M. Polonovski, 59037 Lille, France
,
Charles HerbauxService des maladies du sang, hôpital Huriez, CHRU de Lille, rue M. Polonovski, 59037 Lille, France
,
Sahir JavedService des maladies du sang, hôpital Huriez, CHRU de Lille, rue M. Polonovski, 59037 Lille, France
,
Thierry FaconService des maladies du sang, hôpital Huriez, CHRU de Lille, rue M. Polonovski, 59037 Lille, France
&
Xavier LeleuCorrespondence[email protected]
 show all
Pages 719-731 | Published online: 30 Sep 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yilin Liu, Yuming Song, Yingju Xu, Meixu Jiang & Haibin Lu. (2022) Design, synthesis, and biological evaluation of a novel series of 2-(2,6-dioxopiperidin-3-yl)isoquinoline-1,3(2H,4H)-dione derivatives as cereblon modulators. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1715-1723.
Read now
S. Grammatico, F. Vozella, E. Scalzulli, G. De Angelis & M. T. Petrucci. (2017) Myeloma; living better and living longer - a look at the advances. Expert Review of Quality of Life in Cancer Care 2:3, pages 153-166.
Read now

Articles from other publishers (11)

Guilherme F. S. Fernandes, Juliana R. Lopes, Jean L. Dos Santos & Cauê B. Scarim. (2023) Phthalimide as a versatile pharmacophore scaffold: Unlocking its diverse biological activities. Drug Development Research 84:7, pages 1346-1375.
Crossref
Sudip Kumar Mandal, Agnidipta Das, Anindya Bose, Vagish Dwibedi, Paramita Ganguly, Sipra Sarkar, Ranjana Prakash, Biplab Kumar Dey, Sanjeet Mandal & Santosh Kumar Rath. (2023) Hetero Cyclic Compounds in the Treatment of Triple-Negative Breast Cancer. Current Cancer Therapy Reviews 19:3, pages 237-259.
Crossref
Daniele Derudas & Claudia Concu. 2023. Recent Updates on Multiple Myeloma. Recent Updates on Multiple Myeloma.
Leila Ouni, Ali Ramazani & Hamideh Aghahosseini. (2022) Experimental design optimization for the synthesis of lenalidomide nitro precursor. Research on Chemical Intermediates 49:1, pages 329-339.
Crossref
Sachi Singhal & Shaji Kumar. (2022) Oral Therapies for Multiple Myeloma. Oncology & Haematology 18:2, pages 139.
Crossref
Boris Bozic, Jens Rutner, Chang Zheng, Reinhard Ruckser, Flonza Selimi, Krysztina Racz, Martin Köcher, Georg Tatzreiter & Christian Sebesta. (2021) Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond. Cancers 13:20, pages 5036.
Crossref
Yuhong Wang, Tian Mi, Yiming Li, Weijuan Kan, Gaoya Xu, Jingya Li, Yubo Zhou, Jia Li & Xuefeng Jiang. (2021) Design, synthesis and biological evaluation of thioether-containing lenalidomide and pomalidomide derivatives with anti-multiple myeloma activity. European Journal of Medicinal Chemistry 209, pages 112912.
Crossref
Philippe Moreau, Meletios A. Dimopoulos, Paul G. Richardson, David S. Siegel, Michele Cavo, Paolo Corradini, Katja Weisel, Michel Delforge, Peter O'Gorman, Kevin Song, Christine Chen, Nizar Bahlis, Albert Oriol, Markus Hansson, Martin Kaiser, Pekka Anttila, Reinier Raymakers, Cristina Joao, Gordon Cook, Lars Sternas, Tsvetan Biyukov, Ana Slaughter, Kevin Hong, Jennifer Herring, Xin Yu, Mohamed Zaki & Jesus San-Miguel. (2017) Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis. European Journal of Haematology 99:3, pages 199-206.
Crossref
Helgi van de Velde, Anil Londhe, Ozlem Ataman, Helen L. Johns, Stephen Hill, Emma Landers & Jesse A. Berlin. (2017) Association between complete response and outcomes in transplant-eligible myeloma patients in the era of novel agents. European Journal of Haematology 98:3, pages 269-279.
Crossref
Ellis Benjamin & Yousef M. Hijji. (2017) A Novel Green Synthesis of Thalidomide and Analogs. Journal of Chemistry 2017, pages 1-6.
Crossref
Jonghoon Park, Eok Park, Cheol-Kyu Jung, Seung-Wan Kang, Byung Gyu Kim, Youngjoo Jung, Tae Hun Kim, Ji-Young Lim, Sung-Eun Lee, Chang-Ki Min & Kwang-Ai Won. (2016) Oral proteasome inhibitor with strong preclinical efficacy in myeloma models. BMC Cancer 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.